BOM/524816 (BOM/524816)

Bombay Stock Exchange: BOM/524816 · INR

₹793

-0.70 (-0.1%)· Recorded snapshot

Market cap	155.6B
Revenue (ttm)	34.8B
Net income (ttm)	11.4B
EPS (ttm)	₹63.9
P/E (trailing)	12.4x
P/E (forward)	20.0x
Dividend	₹4.50 (0.57%)
Volume	106,501

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 34.8B
Net income (ttm): 11.4B
EPS (ttm): ₹63.9
P/E (trailing): 12.4x
P/E (forward): 20.0x
Market cap: 155.6B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E20

P25 n/aP50 n/aP75 n/a

Trailing P/E12.4

P25 n/aP50 n/aP75 n/a

ROE16.9

P25 n/aP50 n/aP75 n/a

ROIC10.2

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BOM/524816 indicators

Market & fundamental data

Available fields

241

Groups with data

Currency

INR

Showing 241 of 241 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	INR
Country	India
Country code	IN
Earnings date	2026-11-06
Employees	4,433
Employees change	234
Employees growth	5.57%
Enterprise value	INR 141.4B
Exchange	Bombay Stock Exchange
Financial currency	INR
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	March
Founded	1981
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	No
ISIN number	INE987B01026
Last earnings date	2026-08-14
Last refreshed	2026-10-28
Last stock split date	2015-11-26
Last stock split type	Forward
Market cap	INR 155.6B
Next earnings date	2026-11-06
Price	INR 793.35
Price currency	INR
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	bom/524816
Website	https://www.natcopharma.co.in

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	12.42x
Average P/E ratio (10Y)	24.96x
Average P/E ratio (3Y)	11.72x
Average P/E ratio (5Y)	22.87x
Earnings yield	8.05%
EV/Earnings	12.36x
EV/EBIT	14.33x
EV/EBITDA	11.78x
EV/FCF	10.25x
EV/Sales	4.06x
FCF / EV yield	9.76%
FCF yield	8.87%
Forward P/E	19.96x
Graham number	785.80747
Graham upside	-0.95%
Industry forward P/E	33.08x
Industry P/E	38.9x
Lynch fair value	INR 1,390.37
Lynch upside	75.25%
P/B ratio	1.69x
P/E ratio	12.42x
P/FCF ratio	11.27x
P/OCF ratio	8.8x
P/S ratio	4.46x
Price / tangible book value	1.74x
Price/EBITDA ratio	14.54x
Sector forward P/E	36.12x
Sector P/E	45.5x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	24.56%
EBITDA margin	30.7%
Effective tax rate	7.34%
FCF margin	33.81%
Gross margin	82.64%
Operating margin	24.56%
Pretax margin	35.45%
Profit margin	32.84%
Profit per employee	INR 2.6M
Profitable quarters	17
Profitable years	22
Revenue per employee	INR 7.9M
ROA	7.98%
ROA (5Y)	10.08%
ROCE	13.4%
ROE	16.85%
ROE (5Y)	18.08%
ROIC	10.16%
ROIC (5Y)	19.38%
Tax / revenue	2.6%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	-32.59%
EPS growth (Q)	-57.04%
EPS growth (QoQ)	-22.93%
EPS growth 10Y	20.27%
EPS growth 3Y	12.59%
EPS growth 5Y	24.29%
EPS growth years	0
FCF growth	6.51%
FCF growth 3Y	25.22%
FCF growth 5Y	99.02%
Gross profit growth	-21.18%
Gross profit growth (Q)	-46.37%
Gross profit growth 3Y	7.98%
Gross profit growth 5Y	14.13%
Net income growth	-32.59%
Net income growth (Q)	-57.04%
Net income growth (QoQ)	-22.92%
Net income growth 3Y	11.97%
Net income growth 5Y	23.82%
Net income growth years	0
OCF growth	4.21%
OCF growth 10Y	31.75%
OCF growth 3Y	27.7%
OCF growth 5Y	42.7%
Operating income growth	-50.05%
Operating income growth (Q)	-72.85%
Operating income growth 3Y	-3.47%
Operating income growth 5Y	15.18%
Revenue growth	-20.73%
Revenue growth (Q)	-44.68%
Revenue growth (QoQ)	-1%
Revenue growth 10Y	10.86%
Revenue growth 3Y	5.55%
Revenue growth 5Y	12.91%
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	INR -3.9B
Depreciation and amortization	INR 2.1B
EBIT	INR 8.6B
EBITDA	INR 10.7B
EPS	INR 63.89
Financing cash flow	INR 3B
Free cash flow	INR 13.8B
Gross profit	INR 28.8B
Income taxes	INR 907M
Investing cash flow	INR -20.8B
Net borrowing	INR 4.2B
Net cash flow	INR 789M
Net income	INR 11.4B
Operating income	INR 8.6B
Revenue	INR 34.8B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	INR 514.92
Debt / EBITDA	0.67
Debt / equity	0.08
Debt / FCF	0.52
Interest coverage	18.41
Net cash (debt)	INR 14.2B
Net cash / market cap	9.1%
Net cash growth	-36.18%
Net debt / EBITDA	-1.32
Net debt / equity	-0.15
Net debt / FCF	-1.03
Piotroski F-Score	4
Shareholders' equity	INR 92.2B
Tangible book value	INR 89.6B
Tangible book value per share	INR 500.55
Total cash	INR 21.3B
Total debt	INR 7.1B

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.41
Current ratio	3.01
Inventory turnover	0.8
Quick ratio	1.84
Working capital	INR 33.7B

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	0%
Dividend growth	-10%
Dividend growth (10Y)	8.45%
Dividend growth (3Y)	-20.63%
Dividend growth (5Y)	-5.59%
Dividend growth years	0
Dividend payment date	2026-09-13
Dividend payment years	18
Dividend payout frequency	Semi-Annual
Dividend per share	INR 4.50
Dividend yield	0.57%
Ex-dividend date	2026-08-20
Last dividend	INR 1.50
Payout ratio	7.04%
Shareholder yield	0.57%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	38.15%
10Y return CAGR	4.23%
10Y total return	51.39%
150-day SMA	INR 942.24
15Y price change	1,676.42%
15Y return CAGR	22.16%
15Y total return	1,913.42%
1D price change	-0.09%
1M price change	-5.56%
1M total return	-4.78%
1W price change	1.08%
1W total return	1.08%
1Y price change	-3.87%
1Y return CAGR	-2.57%
1Y total return	-2.57%
20-day SMA	INR 800.91
200-day SMA	INR 930.81
20Y price change	3,376.56%
20Y return CAGR	20.53%
20Y total return	4,085.36%
3M price change	-14.43%
3M total return	-13.58%
3Y price change	-1.56%
3Y return CAGR	0.25%
3Y total return	0.75%
50-day SMA	INR 826.98
50-day SMA vs 200-day SMA	50under200
52-week high	INR 1,226.10
52-week high date	2026-05-12
52-week low	INR 774.00
52-week low date	2026-10-22
5Y price change	-4.36%
5Y return CAGR	-0.02%
5Y total return	-0.11%
6M price change	-27.22%
6M total return	-26.5%
All-time high	INR 1,638.35
All-time high date	2024-09-12
All-time low	INR 2.08
All-time low date	2002-01-14
Average true range (ATR)	INR 18.73
Average volume	36.1K
Change from 52-week high	-35.29%
Change from 52-week low	2.5%
Change from all-time high	-51.58%
Change from all-time low	38,041.83%
Change from open	1.07%
Day's gap	-1.15%
Dollar volume	INR 84.5M
High price	INR 801.85
Low price	INR 779.95
Monthly RSI	42.18
Open price	INR 784.95
Position in 52-week range	61.19%
Previous close	INR 794.05
Price vs 150-day SMA	-15.8%
Price vs 20-day SMA	-0.94%
Price vs 200-day SMA	-14.77%
Price vs 50-day SMA	-4.07%
Relative volume	3.11
RSI	42.23
Sharpe ratio	-0.03
Sharpe ratio (3Y)	0.04
Sharpe ratio (5Y)	0.01
Sortino ratio	0.12
Sortino ratio (3Y)	0.21
Sortino ratio (5Y)	0.19
Volume	106.5K
Weekly RSI	37.23
YTD price change	-12.2%
YTD total return	-11.17%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	83.8M
Shares change (QoQ)	0.01%
Shares change (YoY)	-0%
Shares held by insiders	26.77%
Shares held by institutions	10.44%

Deeper analysis on BOM/524816

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BOM/524816 report

Is a complete BOM/524816 research report available?

No complete published report is available for bom/524816 (BOM/524816) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BOM/524816 (BOM/524816)

Price

Financial snapshot

Fair-value bridge

Latest news · BOM/524816

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BOM/524816 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BOM/524816

Frequently asked questions